Search

Good Brain Tonic Recalled by Liquid Blenz Corp Due to Botulism Risk

Liquid Blenz Corp of Rockville Center, NY is recalling all codes of Good Brain Tonic (16 oz and 32 oz amber bottles) due to potential botulism contamination. The contamination was discovered through analysis by Cornell Food Venture Center and field testing by New York State Department of Agriculture and Markets Food Inspectors. The product was distributed nationwide through retail stores and internet sales. No illnesses have been reported to date.

Nucleic Acid Complexes with Cationic/Anionic Polymers and RNA Molecules

The USPTO published patent application US20260096998A1 for nucleic acid complexes comprising cationic polymers, anionic polymers, and monomeric RNA molecules. The disclosed complexes feature a core structure where the cationic polymer and RNA molecule are encapsulated by the anionic polymer. The application covers linear and non-linear configurations of these complexes for therapeutic uses.

Microbial Compositions and Methods for Fermented Foods

USPTO published patent application US20260096563A1 for microbial compositions comprising purified populations of microorganisms used in producing dough or baked food products. The compositions are designed to enhance fermentation by improving rheological properties, nutritional quality, and shelf-life of dough and baked food products. The application was filed on December 9, 2025, with inventors Cameron Martino and James Gaffney.

Thraustochytrids, Fatty Acid Compositions, and Methods - DSM Assets

USPTO published patent application US20260096578A1 by DSM IP Assets B.V. covering isolated thraustochytrid microorganisms, microbial oils, biomasses, compositions, and associated production and use methods. The application, filed August 13, 2025, lists six inventors and covers CPC classifications spanning food, cosmetic, and pharmaceutical applications.

Inova Diagnostics Aptiva CTD Essential Controls Safety Action

ANSM published safety alert R2608798 informing medical biology laboratories of a quality control recall by Inova Diagnostics for Aptiva CTD Essential Controls used in autoimmune testing. The manufacturer's safety action letter was distributed to affected users on 14 April 2026. Laboratories should review the recalled controls and contact Inova Diagnostics directly for guidance.

Intraocular Lens Podeye Safety Notice - Field Safety Notice R2610293

ANSM has informed health establishments of a safety action implemented by the company Physiol/BVI regarding Podeye intraocular lenses. The safety action is registered under reference number R2610293. Health establishments concerned by this action should review the attached letter from Physiol/BVI dated 14/04/2026.

Maize Gene KRN2 and Uses Thereof Patent Grant US12600976B2

The USPTO granted Patent US12600976B2 to China Agricultural University for KRN2 gene technology controlling kernel row number in maize plants and associated molecular markers for molecular breeding applications. The patent contains 6 claims and names six inventors including Xiaohong Yang, Jiansheng Li, Wenkang Chen, Xuan Zhang, Lichun Cai, and Yirong Zhang.

Biomarker Combinations for NASH and Hepatic Fibrosis Diagnosis

USPTO granted patent US12601747B2 to Bio-Rad Laboratories for biomarker combinations used to diagnose Non-Alcoholic Steatohepatitis (NASH) and hepatic fibrosis status. The patent covers methods and kits for evaluating liver conditions based on three or more biomarker levels in subjects with NAFLD or NASH.

Treating Glioblastoma Using Integrin Pathway Targeting

USPTO granted patent US12601743B2 to The Regents of the University of California for methods of treating drug-resistant glioblastoma (GBM) by targeting the integrin avb3 pathway. The patent covers diagnostic methods to determine tumor sensitivity and treatment methods for tumors identified as avb3+ and Glut3+ with specific molecular signatures. The patent contains 9 claims.

National Nutrition Committee Holds Fourth Meeting in Riyadh

The National Nutrition Committee held its fourth meeting of the third session at SFDA headquarters in Riyadh, chaired by SFDA CEO H.E. Dr. Hisham S. Aljadhey. The Committee reviewed its strategic performance report covering initiatives, projects, and achievements through Q1 2026, as well as the Saudi Food Composition Tables book developed under the Nutrient Content of Foods initiative. The meeting included representatives from various government and private sector entities.